ODDB.org: Open Drug Database

Swissmedic Registration	65091	Date of registration	29.09.2014
Company name	GlaxoSmithKline AG	Revision date
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)	03.04.30.	Revocation Date
Index Therapeuticus (Swissmedic)	03.04.30.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Incruse Ellipta	einzeldosiertes Pulver zur Inhalation	Inhalation Powder (Umeclidinium 62.5 µg)	R03BB07	CI

2025	©ywesee GmbH